Nader is who he is, it's his nature. He's not goin
Post# of 148279
(Total Views: 692)
Posted On: 01/07/2022 6:56:01 PM
Nader is who he is, it's his nature. He's not going to change. He's got the upcoming call that he characterized as another exploration of the saga of Cytodyn to hopefully entice more investment. Maybe there will be updates or some kind of news that will clarify catalysts but it's definitely straight outta the same old playbook
And, to be honest, his unfiltered enthusiasm and willingness to hype and overshare has built a legion of not just monetarily but emotionally invested investors. But, as we all know, when tides turn the guy at the top is the lightning rod and with Nader it's not hard to come up with reasons why he deserves the heat.
Truthfully though, as I posted before, if you look at HGEN, they have a CEO that's the polar opposite temperamentally from Nader and their share price has gone into the toilet also. So whatever CEO's have done or not done, it may have not made much difference. The market is over the little covid underdogs. They may still have great promise but still have nothing tangible in the way of authorizations or approvals to show for almost 2 years of trying. And that's what built the share price up - covid. The alternate reality without the pandemic would probably be much different for CYDY.
The biggest issue staring us in the face with Nader though, is the fact that we should have authorized a bunch of new shares and done a massive financing when the price was high, but hindsight is 20/20. I watched an interview with another micro pharma CEO recently, Robert Foster of Hepion, and he said the biggest mistake in his first stint as a small pharma CEO was not raising money when it was there, even if investors may not have seen the long term value of big dilution when the money was available. He learned the hard way.
Right now Nader has shares to sell but he's got to sell only enough to scrape by because he doesn't want to burn through too many at this price. Hopefully things work themselves out and catalysts pump up the price enough to get a much nicer return on issuances but this is definitely the crisis point in the hero's journey. We all know things can change in a hurry so here's hoping for great news soon. With 12 new sites in Brazil, the possibility is there.
And, to be honest, his unfiltered enthusiasm and willingness to hype and overshare has built a legion of not just monetarily but emotionally invested investors. But, as we all know, when tides turn the guy at the top is the lightning rod and with Nader it's not hard to come up with reasons why he deserves the heat.
Truthfully though, as I posted before, if you look at HGEN, they have a CEO that's the polar opposite temperamentally from Nader and their share price has gone into the toilet also. So whatever CEO's have done or not done, it may have not made much difference. The market is over the little covid underdogs. They may still have great promise but still have nothing tangible in the way of authorizations or approvals to show for almost 2 years of trying. And that's what built the share price up - covid. The alternate reality without the pandemic would probably be much different for CYDY.
The biggest issue staring us in the face with Nader though, is the fact that we should have authorized a bunch of new shares and done a massive financing when the price was high, but hindsight is 20/20. I watched an interview with another micro pharma CEO recently, Robert Foster of Hepion, and he said the biggest mistake in his first stint as a small pharma CEO was not raising money when it was there, even if investors may not have seen the long term value of big dilution when the money was available. He learned the hard way.
Right now Nader has shares to sell but he's got to sell only enough to scrape by because he doesn't want to burn through too many at this price. Hopefully things work themselves out and catalysts pump up the price enough to get a much nicer return on issuances but this is definitely the crisis point in the hero's journey. We all know things can change in a hurry so here's hoping for great news soon. With 12 new sites in Brazil, the possibility is there.
(14)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼